Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor

Journal of Investigative Dermatology

Volumn 114, Issue 1, 2000, Pages 5-13

  Supp, Dorothy M ^a   Supp, Andrew P ^a   Bell, Sheila M ^b   Boyce, Steven T ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Gene therapy; Tissue engineering; Vascular endothelial growth factor; Wound healing

Indexed keywords

VASCULOTROPIN;

ARTICLE; AUTOGRAFT; BURN; DNA MODIFICATION; ENDOTHELIUM CELL; GENE THERAPY; GRAFT FAILURE; HUMAN; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; VASCULARIZATION; WOUND HEALING;

EID: 0034075587     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00824.x     Document Type: Article

References (38)

1. Asahara T, Chen D, Tsurumi Y, et al: Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 94:3291-3302, 1996
2. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM: Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114-1123, 1998
3. Boyce ST: Cultured skin substitutes: a review. Tissue Eng 2:255-266, 1996
4. Boyce ST, Ham R: Cultivation, frozen storage and clonal growth of normal human epidermal keratinocytes in serum-free media. J Tissue Cult Methods 9:83-93, 1985
5. Boyce ST, Foreman TJ, English KB, Stayner N, Cooper ML, Sakabu S, Hansbrough JF: Skin wound closure in athymic mice with cultured human cells, biopolymers and growth factors. Surgery 110:866-876, 1991
6. Boyce ST, Greenhalgh DG, Kagan RJ, et al: Skin anatomy and antigen expression after burn wound closure with composite grafts of cultured skin cells and biopolymers. Plast Reconstr Surg 91:632-641, 1993
7. Boyce ST, Goretsky MJ, Greenhalgh DG, Kagan RJ, Rieman MT, Warden GD: Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg 222:743-752, 1995a
8. Boyce ST, Supp AP, Harriger MD, Greenhalgh DG, Warden GD: Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J Invest Dermatol 104:345-349, 1995b
9. Boyce ST, Harriger MD, Supp AP, Warden GD, Holder IA: Effective management of microbial contamination in cultured skin substitutes after grafting to athymic mice. Wound Rep Regen 5:191-197, 1997
10. Boyce ST, Kagan RJ, Meyer NA, YakubofF K, Warden GD: The 1999 Clinical Research Award: Cultured skin substitutes combined with Integra® to replace native skin autograft and allograft for closure of full-thickness burns. J Burn Care Rehab 20:453-461, 1999
11. Brown LF, Yeo K-T, Berse B, Yeo T-K, Senger DR, Dvorak HF, Van De Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:13375-13379, 1992
12. Carmeliet P, Ferreira V, Breier G, et al: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439, 1996
13. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF: Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 56:172-181, 1996
14. Conn G, Soderman DD, Schaeffer M-T, Wile M, Hatcher VB, Thomas KA: Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87:1323-1327, 1990
15. Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA: Vascular endothelial growth factor is more important than basic fibroblast growth factor during ischemic wound healing. Arch Surg 134:200-205, 1999
16. Detmar M, Yeo K-T, Nagy JA, et al: Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 105:44-50, 1995
17. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP: Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 108:263-268, 1997
18. Detmar M, Brown LF, Schön MP, et al: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111:1-6, 1998
19. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029-1039, 1995
20. Eming SA, Lee J, Snow RG, Tompkins RG, Yarmush ML, Morgan JR: Genetically modified human epidermis overexpressing PDGFA directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice: implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J Invest Dermatol 105:756-763, 1995
21. Ferrara N, Carver-Moore K, Chen H, et al: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442, 1996
22. Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes: implications for normal and impaired wound healing. J Biol Chem 270:12607-12613, 1995
23. Gallico GG III: Biologic skin substitutes. Clin Plast Surg 17:519-526, 1990
24. Harriger MD, Warden GD, Greenhalgh DG, Kagan RJ, Boyce ST: Pigmentation and microanatomy of skin regenerated from composite grafts of cultured cells and biopolymers applied to full-thickness burn wounds. Transplantation 59:702-707, 1995
25. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternate splicing of RNA. Mol Endocrinol 5:1806-1814, 1991
26. 165 in patient with ischaemic limb. Lancet 348:370-374, 1996
27. Larcher F, Robles AI, Duran H, et al: Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res 56:5391-5396, 1996
28. Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL: VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability, and accelerated tumor development. Oncogene 17:303-311, 1998
29. Losordo DW, Vale PR, Symes JF, et al: Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804, 1998
30. Neufeld G, Cohen T, Gengrinovitch S, Poltorak K: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22, 1999
31. Park JE, Keller G-A, Ferrara N: The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326, 1993
32. Rivard A, Silver M, Chen D, et al: Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154:355-363, 1999
33. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulating of ascites fluid. Science 219:983-985, 1983
34. Takeshita S, Weir L, Chen D, et al: Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun 227:628-635, 1996
35. Tsurumi Y, Takeshita S, Chen D, et al: Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94:3281-3290, 1996
36. Vecchi A, Garlanda C, Lampugnani MG, et al: Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 63:247-254, 1994
37. Weninger W, Uthman A, Pammer J, et al: Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest 5:647-657, 1996
38. Young DM, Greulich KM, Weier HG: Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice. J Burn Care Rehabil 17:305-310, 1996